177 related articles for article (PubMed ID: 12888832)
1. Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells.
Wheatley DN; Campbell E
Br J Cancer; 2003 Aug; 89(3):573-6. PubMed ID: 12888832
[TBL] [Abstract][Full Text] [Related]
2. Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells.
Wheatley DN
Semin Cancer Biol; 2005 Aug; 15(4):247-53. PubMed ID: 15886013
[TBL] [Abstract][Full Text] [Related]
3. Control of argininosuccinate synthetase by arginine in human lymphoblasts.
Irr JD; Jacoby LB
Somatic Cell Genet; 1978 Jan; 4(1):111-24. PubMed ID: 628880
[TBL] [Abstract][Full Text] [Related]
4. Citrulline-argininosuccinate-arginine cycle coupled to Ca2+-signaling in rat pancreatic beta-cells.
Nakata M; Yada T; Nakagawa S; Kobayashi K; Maruyama I
Biochem Biophys Res Commun; 1997 Jun; 235(3):619-24. PubMed ID: 9207208
[TBL] [Abstract][Full Text] [Related]
5. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
6. L-citrulline recycling by argininosuccinate synthetase and lyase in rat gastric fundus.
Van Geldre LA; Timmermans JP; Lefebvre RA
Eur J Pharmacol; 2002 Nov; 455(2-3):149-60. PubMed ID: 12445581
[TBL] [Abstract][Full Text] [Related]
7. Recycling of L-citrulline to sustain nitric oxide-dependent enteric neurotransmission.
Shuttleworth CW; Burns AJ; Ward SM; O'Brien WE; Sanders KM
Neuroscience; 1995 Oct; 68(4):1295-304. PubMed ID: 8545001
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.
Bobak YP; Vynnytska BO; Kurlishchuk YV; Sibirny AA; Stasyk OV
Cell Biol Int; 2010 Nov; 34(11):1085-9. PubMed ID: 20653567
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.
Bowles TL; Kim R; Galante J; Parsons CM; Virudachalam S; Kung HJ; Bold RJ
Int J Cancer; 2008 Oct; 123(8):1950-5. PubMed ID: 18661517
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.
Yoon CY; Shim YJ; Kim EH; Lee JH; Won NH; Kim JH; Park IS; Yoon DK; Min BH
Int J Cancer; 2007 Feb; 120(4):897-905. PubMed ID: 17096330
[TBL] [Abstract][Full Text] [Related]
11. Induction of citrulline-nitric oxide (NO) cycle enzymes and NO production in immunostimulated rat RPE-J cells.
Koga T; Zhang WY; Gotoh T; Oyadomari S; Tanihara H; Mori M
Exp Eye Res; 2003 Jan; 76(1):15-21. PubMed ID: 12589771
[TBL] [Abstract][Full Text] [Related]
12. Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability.
Kurlishchuk Y; Vynnytska-Myronovska B; Grosse-Gehling P; Bobak Y; Manig F; Chen O; Merker SR; Henle T; Löck S; Stange DE; Stasyk O; Kunz-Schughart LA
Oncotarget; 2016 Nov; 7(45):73292-73308. PubMed ID: 27689335
[TBL] [Abstract][Full Text] [Related]
13. Metabolic cooperation between argininosuccinate synthetase and argininosuccinate lyase deficient human fibroblasts.
Davidson JS; Baumgarten IM; Harley EH
Exp Cell Res; 1984 Feb; 150(2):367-78. PubMed ID: 6692857
[TBL] [Abstract][Full Text] [Related]
14. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis.
Hattori Y; Campbell EB; Gross SS
J Biol Chem; 1994 Apr; 269(13):9405-8. PubMed ID: 7511585
[TBL] [Abstract][Full Text] [Related]
15. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase.
Shen LJ; Lin WC; Beloussow K; Shen WC
Cancer Lett; 2003 Mar; 191(2):165-70. PubMed ID: 12618329
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
17. Inability of rat alveolar macrophages to recycle L-citrulline to L-arginine despite induction of argininosuccinate synthetase mRNA and protein, and inhibition of nitric oxide synthesis by exogenous L-citrulline.
Hammermann R; Bliesener N; Mössner J; Klasen S; Wiesinger H; Wessler I; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):601-7. PubMed ID: 9879717
[TBL] [Abstract][Full Text] [Related]
18. Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines.
Wheatley DN; Kilfeather R; Stitt A; Campbell E
Cancer Lett; 2005 Sep; 227(2):141-52. PubMed ID: 16112417
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary artery endothelial cells.
Su Y; Block ER
Am J Physiol; 1995 Nov; 269(5 Pt 1):L581-7. PubMed ID: 7491976
[TBL] [Abstract][Full Text] [Related]
20. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines.
Flodström M; Niemann A; Bedoya FJ; Morris SM; Eizirik DL
Endocrinology; 1995 Aug; 136(8):3200-6. PubMed ID: 7628352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
